Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
HCV-geïnduceerde epigenetische veranderingen geassocieerd met HCC-risico na SVR
sep 2019 | Hepatitis